Publication

Human granulocytes detected with a piezoimmunosensor

Michael Graetzel
1993
Journal Articles

Abstract

We have developed a reusable piezoelectric immunosensor for human granulocytes. Three different methods for immobilization of the anti-CD 18 antibody on the gold electrode of the immunosensor were tested. The methods showed some differences in terms of stability and sensitivity. Applying an anti-CD 18 antibody layer onto a 10-MHz AT-cut crystal resulted for 2 × 103 to 3 × 105 cells on the surface in a linear frequency change. The modified crystal was stable for eight weeks when stored desiccated at room temperature.

Official source

https://infoscience.epfl.ch/entities/publication/dd455e14-326a-470e-a891-24cb490e094b

About this result

This page is automatically generated and may contain information that is not correct, complete, up-to-date, or relevant to your search query. The same applies to every other page on this website. Please make sure to verify the information with EPFL's official sources.

Graph Chat

Chat with Graph Search

Ask any question about EPFL courses, lectures, exercises, research, news, etc. or try the example questions below.

DISCLAIMER: The Graph Chatbot is not programmed to provide explicit or categorical answers to your questions. Rather, it transforms your questions into API requests that are distributed across the various IT services officially administered by EPFL. Its purpose is solely to collect and recommend relevant references to content that you can explore to help you answer your questions.

Michael Graetzel
1993
Journal Articles

Abstract

Official source

https://infoscience.epfl.ch/entities/publication/dd455e14-326a-470e-a891-24cb490e094b

About this result

Related concepts (26)

Monoclonal antibody therapy

Monoclonal antibody therapy is a form of immunotherapy that uses monoclonal antibodies (mAbs) to bind monospecifically to certain cells or proteins. The objective is that this treatment will stimulate the patient's immune system to attack those cells. Alternatively, in radioimmunotherapy a radioactive dose localizes a target cell line, delivering lethal chemical doses. Antibodies are used to bind to molecules involved in T-cell regulation to remove inhibitory pathways that block T-cell responses.

Granulocyte colony-stimulating factor

Granulocyte colony-stimulating factor (G-CSF or GCSF), also known as colony-stimulating factor 3 (CSF 3), is a glycoprotein that stimulates the bone marrow to produce granulocytes and stem cells and release them into the bloodstream. Functionally, it is a cytokine and hormone, a type of colony-stimulating factor, and is produced by a number of different tissues. The pharmaceutical analogs of naturally occurring G-CSF are called filgrastim and lenograstim.

Granulocyte-macrophage colony-stimulating factor

Granulocyte-macrophage colony-stimulating factor (GM-CSF), also known as colony-stimulating factor 2 (CSF2), is a monomeric glycoprotein secreted by macrophages, T cells, mast cells, natural killer cells, endothelial cells and fibroblasts that functions as a cytokine. The pharmaceutical analogs of naturally occurring GM-CSF are called sargramostim and molgramostim. Unlike granulocyte colony-stimulating factor, which specifically promotes neutrophil proliferation and maturation, GM-CSF affects more cell types, especially macrophages and eosinophils.